Suppr超能文献

口服抗凝治疗(华法林与醋硝香豆素)稳定性的比较研究

[Comparative study of the stability of oral anticoagulant treatments (warfarin vs acenocoumarol)].

作者信息

Amián A, Rodríguez J N, Muñiz R, Diéguez J C, Moreno M V, Quesada J A, Cañavate M, Fernández-Jurado A, Martino M L, Prados D

机构信息

Servicio de Hematología y Hemoterapia, Hospital Juan Ramón Jiménez.

出版信息

Sangre (Barc). 1996 Feb;41(1):9-11.

PMID:8779047
Abstract

PURPOSE

To compare the stability of the effect of two oral anticoagulants, one of them (acenocoumarol) with a short half life and the other one with a long half life (warfarin) in patients in the stable phase of treatment (at least 2 months with treatment before entering the study).

PATIENTS AND METHODS

During a year period (January-December 1993) a comparative study of two groups of 53 patients each was performed: group 1 patients were treated with warfarin and group 2 with acenocoumarol. Both groups were paired with respect to age, sex, diagnosis for anticoagulant therapy and desired therapeutic range (INR 3-4.5). The mean value of controls per patient, the dosage changes, the evolutive controls and the incidence of haemorrhagic and thromboembolic episodes were studied.

RESULTS

The controls performed in group 1 were 728 in total with a mean value of 13.74 per patient and 800 in group 2 with a mean value of 15.09 per patient. A change in the dosage was performed in 214 controls in patients of group 1 and in 269 of group 2. Seventeen patients had 38 haemorrhagic episodes (2 major and 36 minor) in group 1, and 6 of group 2 had 20 episodes (2 major and 18 minor). Significant differences were observed in the mean value of controls (p = 0.04), the evolutive controls (p < 0.001), the global incidence of haemorrhages (p = 0.008) and incidence of minor ones (p = 0.006). No significant differences in dosage were observed. In both groups no thromboembolic episodes during the period of study were reported.

CONCLUSIONS

Anticoagulant treatment with warfarin is more stable than with acenocoumarol. The total controls and the mean value of controls per patient are decreased. Nevertheless with warfarin we have observed a greater incidence of haemorrhagic episodes.

摘要

目的

比较两种口服抗凝剂的治疗效果稳定性,其中一种(醋硝香豆素)半衰期短,另一种(华法林)半衰期长,研究对象为处于治疗稳定期的患者(入组研究前至少接受2个月治疗)。

患者与方法

在一年期间(1993年1月至12月),对两组各53例患者进行了对比研究:第1组患者接受华法林治疗,第2组接受醋硝香豆素治疗。两组在年龄、性别、抗凝治疗诊断及期望治疗范围(国际标准化比值3 - 4.5)方面进行了配对。研究了每位患者的对照均值、剂量变化、进展性对照以及出血和血栓栓塞事件的发生率。

结果

第1组共进行了728次对照,每位患者均值为13.74次;第2组进行了800次对照,每位患者均值为15.09次。第1组患者中有214次对照时进行了剂量调整,第2组有269次。第1组有17例患者发生38次出血事件(2次严重出血和36次轻微出血),第2组有6例患者发生20次事件(2次严重出血和18次轻微出血)。在对照均值(p = 0.04)、进展性对照(p < 0.001)、出血总体发生率(p = 0.008)和轻微出血发生率(p = 0.006)方面观察到显著差异。未观察到剂量方面的显著差异。两组在研究期间均未报告血栓栓塞事件。

结论

华法林抗凝治疗比醋硝香豆素更稳定。总对照次数和每位患者的对照均值减少。然而,使用华法林时我们观察到出血事件的发生率更高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验